- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02985931
Single-scan Rest/Stress Imaging With Cadmium Zinc Telluride-based SPECT for Coronary Flow Quantification
December 4, 2016 updated by: Tzu-Chen Yen, Chang Gung Memorial Hospital
The investigators aim to address this issue with novel image quantification methods using CZT-based SPECT, which is capable of dynamic data acquisition and therefore feasible for the quantification of the coronary flow.
The investigators will use kinetic modeling techniques to design a study that allows the absolute flow quantification.
To make this study practical, the investigators will develop a protocol that includes the acquisition of both the rest and stress scan within the same scan that is shorter than 30 minutes.
The SPECT-measured flow will be validated against the flow measured with cardiac MRI scans.
Patients with high CAD risk will be recruited for the clinical trial.
Data from these human subjects will be used for determination of the performance of the developed algorithm.
With the proposed rapid scan with absolute quantification capabilities, the investigators expect to increase the diagnosis accuracy while maintaining the patient throughput.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
30
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects who are suspected with coronary artery diseases and need imaging exams.
Description
Inclusion Criteria:
- Subjects with high possibility of coronary artery disease after being evaluated by a cardiologist.
- > 20 years old.
- Not under infection or other conditions inappropriate for being recruited.
- Without myocardial infarction within one week.
- With stable blood pressure.
- Subjects with normal kidney functions and without allergic reactions to MRI contrast agents.
Exclusion Criteria:
- Subjects who cannot take a SPECT scan or do not agree to sign the informed consent.
- Pregnant subjects or subjects who are currently breast-feeding.
- Those currently under radiation therapies.
- Patients with pleural effusion.
- Patients who are allergic to SPECT tracers.
- Patients with serious psychological disorders.
- Patients with asthma.
- Patients with stroke within a week.
- Patients with AV block.
- Patients with sinus syndrome.
- Subjects who are currently under other clinical trials.
- Subjects with poor kidney functions who are inappropriate for MRI contrast agents.
- Subjects with pacemakers.
- Subjects with Claustrophobia.
- Subjects who cannot hold breath for cardiac MRI studies.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Suspected CAD subjects
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Correlation between SPECT- and MRI-measured flow values
Time Frame: through study completion, an average of 3 year
|
through study completion, an average of 3 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tzu-Chen Yen, MD, PhD, Chang Gung Memorial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
December 1, 2016
First Submitted That Met QC Criteria
December 4, 2016
First Posted (Estimate)
December 7, 2016
Study Record Updates
Last Update Posted (Estimate)
December 7, 2016
Last Update Submitted That Met QC Criteria
December 4, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 101-0453A3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.